NO20061107L - CRF-antagonister og heterobrcykliske forbindelser - Google Patents
CRF-antagonister og heterobrcykliske forbindelserInfo
- Publication number
- NO20061107L NO20061107L NO20061107A NO20061107A NO20061107L NO 20061107 L NO20061107 L NO 20061107L NO 20061107 A NO20061107 A NO 20061107A NO 20061107 A NO20061107 A NO 20061107A NO 20061107 L NO20061107 L NO 20061107L
- Authority
- NO
- Norway
- Prior art keywords
- optionally
- substituted
- crf antagonists
- heterocyclic compounds
- optionally substituted
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 101100440695 Dictyostelium discoideum corB gene Proteins 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000005750 substituted cyclic group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003316662 | 2003-09-09 | ||
| JP2004122409 | 2004-04-19 | ||
| PCT/JP2004/013386 WO2005026126A1 (fr) | 2003-09-09 | 2004-09-08 | Antagonistes crf et composes heterobicycliques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061107L true NO20061107L (no) | 2006-06-09 |
Family
ID=34315633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061107A NO20061107L (no) | 2003-09-09 | 2006-03-08 | CRF-antagonister og heterobrcykliske forbindelser |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070027156A1 (fr) |
| EP (1) | EP1666468A4 (fr) |
| JP (1) | JPWO2005026126A1 (fr) |
| KR (1) | KR20060072142A (fr) |
| AU (1) | AU2004272437A1 (fr) |
| BR (1) | BRPI0414238A (fr) |
| CA (1) | CA2538026A1 (fr) |
| IL (1) | IL174152A0 (fr) |
| MX (1) | MXPA06002618A (fr) |
| NO (1) | NO20061107L (fr) |
| RU (1) | RU2006111469A (fr) |
| WO (1) | WO2005026126A1 (fr) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006092428A2 (fr) * | 2005-03-02 | 2006-09-08 | Basf Aktiengesellschaft | 7-amino-azolopyrimidine 2-substituee, son procede de fabrication et son utilisation pour lutter contre les champignons nuisibles, et agents renfermant ce compose |
| US7723336B2 (en) | 2005-09-22 | 2010-05-25 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| WO2007056618A1 (fr) * | 2005-11-10 | 2007-05-18 | Board Of Supervisors Of Louisiana State University & Agricultural & Mechanical College | Compositions et procedes pour le traitement de l'addiction et d'autres troubles neuropsychiatriques |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| EP1961745A1 (fr) | 2005-12-12 | 2008-08-27 | Ono Pharmaceutical Co., Ltd. | Compose heterocyclique bicyclique |
| WO2007069671A1 (fr) | 2005-12-15 | 2007-06-21 | Ono Pharmaceutical Co., Ltd. | Compose heterocyclique bicyclique |
| US8063050B2 (en) | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| ATE532789T1 (de) | 2006-07-06 | 2011-11-15 | Array Biopharma Inc | Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren |
| WO2008006025A1 (fr) | 2006-07-06 | 2008-01-10 | Array Biopharma Inc. | Dihydrofuro pyrimidines comme inhibiteurs de la protéine kinase akt |
| WO2008006032A1 (fr) | 2006-07-06 | 2008-01-10 | Array Biopharma Inc. | Cyclopenta [d] pyrimidines utiles en tant qu'inhibiteurs de la protéine kinase akt |
| TW200902019A (en) | 2007-04-26 | 2009-01-16 | Ono Pharmaceutical Co | Dicyclic heterocyclic compound |
| AR067413A1 (es) | 2007-07-05 | 2009-10-07 | Genentech Inc | Compuestos heterociclicos que contienen ciclopenta[d]pirimidina inhibidores de proteinquinasas akt, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de las mismas para el tratamiento de enfermedades hiperproliferativas, tales como cancer |
| US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
| US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| ATE522509T1 (de) * | 2007-07-05 | 2011-09-15 | Array Biopharma Inc | Pyrimidylcyclopentane als inhibitoren der akt- proteinkinase |
| EP2178375B1 (fr) * | 2007-07-20 | 2014-09-24 | Merck Sharp & Dohme Corp. | Dérivés de la pyrazoloý1,5-a¨pyrimidine |
| ES2394759T3 (es) | 2008-01-08 | 2013-02-05 | Array Biopharma, Inc. | Pirrolopiridinas como inhibidores de quinasa |
| US8372842B2 (en) * | 2008-01-09 | 2013-02-12 | Array Biopharma Inc. | Pyrazolopyridines as kinase inhibitors |
| CN101932565B (zh) * | 2008-01-09 | 2013-06-12 | 阵列生物制药公司 | 作为akt蛋白激酶抑制剂的羟基化嘧啶基环戊烷 |
| WO2009089459A1 (fr) * | 2008-01-09 | 2009-07-16 | Array Biopharma Inc. | Pyrimidylcyclopentanes hydroxylés utilisés comme inhibiteurs de protéine kinase akt |
| JP5394404B2 (ja) | 2008-02-06 | 2014-01-22 | ブリストル−マイヤーズ スクイブ カンパニー | キナーゼ阻害剤として有用な置換イミダゾピリダジン類 |
| US8461163B2 (en) | 2008-03-31 | 2013-06-11 | Takeda Pharmaceutical Company Limited | Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1 |
| CA2730843A1 (fr) | 2008-07-15 | 2010-01-21 | Sanofi-Aventis | Oxazolopyrimidines comme agonistes du recepteur edg-1 |
| WO2010074284A1 (fr) | 2008-12-26 | 2010-07-01 | 味の素株式会社 | Composé de pyrazolopyrimidine |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| CN102762572A (zh) | 2010-02-01 | 2012-10-31 | 诺瓦提斯公司 | 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物 |
| WO2011092293A2 (fr) | 2010-02-01 | 2011-08-04 | Novartis Ag | Dérivés de cyclohexylamide utilisés en tant qu'antagonistes du récepteur du crf |
| CN102753527B (zh) | 2010-02-02 | 2014-12-24 | 诺华股份有限公司 | 用作crf受体拮抗剂的环己基酰胺衍生物 |
| MX359263B (es) | 2010-06-16 | 2018-09-20 | Board Of Supervisors Of Louisiana State Univ & Agricultural & Mechanical College | Composiciones y métodos para el tratamiento de adicciones, trastornos psiquiátricos , y enfermedades neurodegenerativas. |
| US8927562B2 (en) | 2010-09-28 | 2015-01-06 | Merck Sharp & Dohme Corp. | Fused tricyclic inhibitors of mammalian target of rapamycin |
| WO2012047569A1 (fr) * | 2010-09-28 | 2012-04-12 | Schering Corporation | Composés tricycliques accolés inhibiteurs de la cible mammifère de la rapamycine |
| MX2013003913A (es) | 2010-10-08 | 2013-09-26 | Abbvie Inc | Compuestos de furo [3, 2-d] pirimidina. |
| JP6147246B2 (ja) | 2011-04-01 | 2017-06-14 | ジェネンテック， インコーポレイテッド | Ａｋｔ及びｍｅｋ阻害剤化合物の組み合わせ、及び使用方法 |
| RU2631240C2 (ru) | 2011-04-01 | 2017-09-20 | Дженентек, Инк. | Комбинации соединений-ингибиторов акт и абиратерона, и способы применения |
| US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
| EP2852591A1 (fr) | 2012-05-03 | 2015-04-01 | Novartis AG | Sel de l-malate de dérivés de 2,7-diaza-spiro[4.5]déc-7-yle et ses formes cristallines à titre d'agonistes des récepteurs de ghreline |
| KR101657616B1 (ko) * | 2013-05-24 | 2016-09-19 | 주식회사유한양행 | 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법 |
| WO2017019537A1 (fr) * | 2015-07-24 | 2017-02-02 | University Of Louisville Research Foundation, Inc. | Composés, compositions, procédés pour le traitement de maladies et procédés pour la préparation de composés |
| BR112018012914B1 (pt) | 2015-12-22 | 2023-04-18 | SHY Therapeutics LLC | Composto, uso de um composto e composição farmacêutica |
| WO2018165649A1 (fr) | 2017-03-10 | 2018-09-13 | Embera Neurotherapeutics, Inc. | Compositions pharmaceutiques et leurs utilisations |
| IL270525B2 (en) | 2017-05-12 | 2024-06-01 | Enanta Pharm Inc | Apoptosis signal-regulated kinase 1 inhibitors and methods of using them |
| EP4331679A3 (fr) | 2017-06-21 | 2024-04-03 | Shy Therapeutics LLC | Composés interagissant avec la superfamille ras destinés à être utilisés dans le traitement de cancers, de maladies inflammatoires, de rasopathies et de maladies fibrotiques |
| HUE068033T2 (hu) | 2017-07-28 | 2024-12-28 | Takeda Pharmaceuticals Co | TYK2 inhibitorok és azok felhasználása |
| JP7328254B2 (ja) | 2018-05-02 | 2023-08-16 | エナンタ ファーマシューティカルズ インコーポレイテッド | アポトーシスシグナル調節キナーゼ１阻害剤を含むテトラゾール及びその使用方法 |
| US11345699B2 (en) | 2018-11-19 | 2022-05-31 | Enanta Pharmaceuticals, Inc. | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
| EP3898609A1 (fr) | 2018-12-19 | 2021-10-27 | Shy Therapeutics LLC | Composés interagissant avec la superfamille ras pour le traitement de cancers, de maladies inflammatoires, de rasopathies et de maladie fibrotique |
| CA3163242A1 (fr) * | 2019-12-02 | 2021-06-10 | Aarash BORDBAR | Traitement de troubles cognitifs a l'aide de trapidil |
| AU2021350590A1 (en) * | 2020-09-25 | 2023-04-27 | Consejo Superior De Investigaciones Cientificas (Csic) - Spanish National Research Council (Csic) | Glycosidase inhibitors and uses thereof |
| WO2023121207A1 (fr) * | 2021-12-20 | 2023-06-29 | 재단법인 대구경북첨단의료산업진흥재단 | Composition pharmaceutique inhibant aak1, pour prévenir ou traiter des maladies virales ou des maladies cérébrales |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD265317A5 (de) * | 1985-12-05 | 1989-03-01 | Bayer Ag,De | Herbizide und pflanzenwuchsregulierende mittel |
| JP2660086B2 (ja) * | 1990-07-03 | 1997-10-08 | 明治製菓株式会社 | 脳及び心機能障害改善剤 |
| DE59107545D1 (de) * | 1990-12-14 | 1996-04-18 | Basf Ag | Salicylaldehyd- und Salicylsäurederivate sowie deren Schwefelanaloge, Verfahren und Zwischenprodukte zu ihrer Herstellung |
| JPH0748359A (ja) * | 1992-10-16 | 1995-02-21 | Nippon Soda Co Ltd | 縮合ピリミジン誘導体、除草剤および農園芸用殺菌剤 |
| AU688087B2 (en) * | 1994-08-13 | 1998-03-05 | Yuhan Corporation | Novel pyrimidine derivatives and processes for the preparation thereof |
| US6107300A (en) * | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
| US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
| US6548509B2 (en) * | 1999-10-22 | 2003-04-15 | Neurogen Corporation | 3-aryl substituted pyrazolo[4,3-D]pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands |
| US7067520B2 (en) * | 2000-11-17 | 2006-06-27 | Ishihara Sangyo Kaisha, Ltd. | Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts |
| WO2002088079A2 (fr) * | 2001-05-01 | 2002-11-07 | Bristol-Myers Squibb Company | Inhibiteurs doubles de pde 7 et pde 4 |
| KR20050058507A (ko) * | 2002-09-04 | 2005-06-16 | 쉐링 코포레이션 | 사이클린 의존성 키나제 억제제로서의 피라졸로피리미딘 |
| KR20050057139A (ko) * | 2002-09-04 | 2005-06-16 | 쉐링 코포레이션 | 사이클린 의존성 키나제 억제제로서의 피라졸로피리미딘 |
| AU2003263071B2 (en) * | 2002-09-04 | 2007-03-15 | Merck Sharp & Dohme Llc | Pyrazolopyrimidines as cyclin-dependent kinase inhibitors |
| CA2516824A1 (fr) * | 2003-02-28 | 2004-09-10 | Teijin Pharma Limited | Derives de pyrazolo[1,5-a]pyrimidine |
| GB0305559D0 (en) * | 2003-03-11 | 2003-04-16 | Teijin Ltd | Compounds |
-
2004
- 2004-09-08 MX MXPA06002618A patent/MXPA06002618A/es not_active Application Discontinuation
- 2004-09-08 WO PCT/JP2004/013386 patent/WO2005026126A1/fr not_active Ceased
- 2004-09-08 BR BRPI0414238-1A patent/BRPI0414238A/pt not_active Application Discontinuation
- 2004-09-08 AU AU2004272437A patent/AU2004272437A1/en not_active Abandoned
- 2004-09-08 JP JP2005513939A patent/JPWO2005026126A1/ja not_active Withdrawn
- 2004-09-08 US US10/571,271 patent/US20070027156A1/en not_active Abandoned
- 2004-09-08 EP EP04773059A patent/EP1666468A4/fr not_active Withdrawn
- 2004-09-08 CA CA002538026A patent/CA2538026A1/fr not_active Abandoned
- 2004-09-08 RU RU2006111469/04A patent/RU2006111469A/ru not_active Application Discontinuation
- 2004-09-08 KR KR1020067004781A patent/KR20060072142A/ko not_active Withdrawn
-
2006
- 2006-03-07 IL IL174152A patent/IL174152A0/en unknown
- 2006-03-08 NO NO20061107A patent/NO20061107L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060072142A (ko) | 2006-06-27 |
| IL174152A0 (en) | 2006-08-01 |
| AU2004272437A1 (en) | 2005-03-24 |
| US20070027156A1 (en) | 2007-02-01 |
| JPWO2005026126A1 (ja) | 2006-11-16 |
| EP1666468A4 (fr) | 2007-03-21 |
| CA2538026A1 (fr) | 2005-03-24 |
| MXPA06002618A (es) | 2006-06-05 |
| EP1666468A1 (fr) | 2006-06-07 |
| RU2006111469A (ru) | 2007-10-27 |
| WO2005026126A1 (fr) | 2005-03-24 |
| BRPI0414238A (pt) | 2006-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20061107L (no) | CRF-antagonister og heterobrcykliske forbindelser | |
| TW200510381A (en) | Novel 2-pyridinecarboxamide derivatives | |
| TW200633991A (en) | Chemical compounds | |
| CO6261382A2 (es) | Compuestos de imidazotiazol como moduladores de sirtuina | |
| UA110706C2 (uk) | Похідна 6-ацил-1,2,4-триазин-3,5-діону та гербіциди | |
| DE602005023343D1 (de) | Pyrimidinderivate als gpcr-agonisten | |
| PE20130385A1 (es) | Derivados del acido naft-2-ilacetico para tratar el sida | |
| EA201201178A1 (ru) | Пестицидные смеси, включающие изоксазолиновые производные и инсектицид или нематоцидное биологическое средство | |
| NO20075809L (no) | DNA-PK inhibitorer | |
| CA2616580A1 (fr) | Inhibiteurs macrocycliques du virus de l'hepatite c | |
| NZ602099A (en) | Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient | |
| NO20053614L (no) | Nye pyridazin-3(2H)-on-derivater | |
| EA200600317A1 (ru) | Производные омега-карбоксиарилдифенилмочевины (варианты), фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с их использованием (варианты) | |
| ATE365551T1 (de) | Fusionierte heteroaryl-derivative zur verwendung als p38 kinase inhibitoren zur behandlung von u.a rheumatischer arthritis | |
| BR0312129A (pt) | Derivados de espiroindolinapiperidina | |
| NO20083006L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av fedme | |
| NZ590285A (en) | Heteroaryl derivatives as dgat1 inhibitors | |
| EA201170522A1 (ru) | Новые гетероциклические азотсодержащие соединения, их получение и их применение в качестве антибактериальных лекарственных средств | |
| NO20055688L (no) | Organiske forbindelser | |
| EA200971101A1 (ru) | Соединения на основе лантибиотиков, обладающие противомикробной активностью | |
| WO2009018065A3 (fr) | Nouveaux activateurs de glucokinase et procédés pour les utiliser | |
| NO20082209L (no) | Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer | |
| NO20082116L (no) | Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse | |
| NO20053762L (no) | Kondensert furanforbindelse. | |
| AR073609A1 (es) | COMPUESTOS DE ANILLO FUSIONADO Y USO DE LOS MISMOS EN EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA ACTIVACIoN DE LA GLUCOQUINASA. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |